Jan 07, 2016 13:45 pm UTC| Business
HENDERSON, NV, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Double Crown Resources, Inc. (DDCC), a fully reporting company, is very pleased to announce that a final contract has been signed with a major buyer of precious metals...
Jan 07, 2016 13:41 pm UTC| Business
MALVERN, Pa., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE:VSH) announced today that Johan Vandoorn, Executive Vice President and Chief Technical Officer, and Peter Henrici, Senior Vice President,...
Avid Announces Changes to Board of Directors
Jan 07, 2016 13:30 pm UTC| Business
BURLINGTON, Mass., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Avid® (Nasdaq:AVID) (“Avid” or the “Company”), a leading provider of digital media technologies for media organizations and independent professionals, today announced...
DAVIDsTEA Inc. Continues Store Expansion, Opening 10 New Stores in North America
Jan 07, 2016 13:30 pm UTC| Business
MONTREAL, Jan. 07, 2016 (GLOBE NEWSWIRE) -- DAVIDsTEA Inc. (NASDAQ:DTEA) (the “Company” or “DAVIDsTEA”) is pleased to announce the opening of ten new stores across North America, which will feature DAVIDsTEA’s full line...
Retail TouchPoints Exclusive Store Tours Interview: Barry Beck, COO & Founder, Bluemercury
Jan 07, 2016 13:30 pm UTC| Business
HASBROUCK HEIGHTS, N.J., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Retail TouchPoints (RTP) has just released an exclusive video interview with Barry Beck, the Founder and COO of Bluemercury — a luxury skincare, cosmetics and...
Cellectar Biosciences to Present at the 2016 Biotech Showcase
Jan 07, 2016 13:30 pm UTC| Business
MADISON, Wis., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, announces today its CEO, Jim Caruso, will be presenting at the Biotech Showcase in...
Neurotrope Initiates Phase 2b Study of Bryostatin for Treatment of Alzheimer’s Disease
Jan 07, 2016 13:30 pm UTC| Business
NEWARK, N.J., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Neurotrope, Inc. (OTCBB:NTRP) today announced the initiation of a Phase 2b clinical trial of lead candidate Bryostatin 1 for the treatment of Alzheimer’s Disease. The...